ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 104 filers reported holding ADICET BIO INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,117 | -89.0% | 12,494 | -80.5% | 0.00% | – |
| Q2 2023 | $155,520 | -80.1% | 64,000 | -52.9% | 0.00% | – |
| Q1 2023 | $782,231 | +132.5% | 135,804 | +260.9% | 0.00% | – |
| Q4 2022 | $336,421 | -87.1% | 37,631 | -79.5% | 0.00% | – |
| Q3 2022 | $2,610,000 | +112.4% | 183,600 | +118.0% | 0.00% | – |
| Q2 2022 | $1,229,000 | +21.2% | 84,205 | +65.8% | 0.00% | – |
| Q1 2022 | $1,014,000 | -76.0% | 50,800 | -79.0% | 0.00% | – |
| Q4 2021 | $4,222,000 | +2000.5% | 241,432 | +1134.1% | 0.00% | – |
| Q2 2021 | $201,000 | -82.2% | 19,563 | -77.3% | 0.00% | – |
| Q1 2021 | $1,129,000 | +60.8% | 86,292 | +72.7% | 0.00% | – |
| Q4 2020 | $702,000 | – | 49,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |